D
Telix Pharmaceuticals Limited TLX
$9.36 -$0.07-0.74% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 667.41M 595.08M 514.99M 470.19M 421.97M
Total Other Revenue -- -- -- -- --
Total Revenue 667.41M 595.08M 514.99M 470.19M 421.97M
Cost of Revenue 306.98M 257.73M 196.65M 180.67M 163.38M
Gross Profit 360.43M 337.35M 318.34M 289.52M 258.59M
SG&A Expenses 170.59M 155.37M 137.24M 123.55M 108.94M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses 13.01M 10.14M 5.45M 5.04M 4.62M
Total Operating Expenses 645.15M 566.83M 467.40M 427.34M 384.15M
Operating Income 22.26M 28.25M 47.58M 42.85M 37.82M
Income Before Tax 9.29M 17.54M 36.75M 34.80M 32.68M
Income Tax Expenses -1.81M -2.30M 3.94M 2.23M 502.50K
Earnings from Continuing Operations 11.10 19.84 32.81 32.57 32.18
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 11.10M 19.84M 32.81M 32.57M 32.18M
EBIT 22.26M 28.25M 47.58M 42.85M 37.82M
EBITDA 30.60M 34.67M 51.33M 46.62M 41.61M
EPS Basic 0.03 0.05 0.09 0.09 0.09
Normalized Basic EPS 0.04 0.05 0.08 0.07 0.06
EPS Diluted 0.03 0.05 0.08 0.09 0.09
Normalized Diluted EPS 0.04 0.05 0.08 0.07 0.06
Average Basic Shares Outstanding 1.34B 1.66B 1.65B 1.64B 1.62B
Average Diluted Shares Outstanding 1.38B 1.72B 1.72B 1.70B 1.68B
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --